Hospital CUF Descobertas
About Hospital CUF Descobertas
"O Hospital CUF Descobertas, em Lisboa, disponibiliza um conjunto de serviços clínicos, como Atendimento Permanente de Adultos, Pediátrico e de Ginecologia-Obstetrícia."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Janssen Research & Development, LLC
2
Pfizer
2
Academia Cuf Descobertas
1
Actelion
1
Alector Inc.
1
Amgen
1
BioCeryx
1
Daiichi Sankyo, Inc.
1
European Organisation for Research and Treatment of Cancer - EORTC
1
Gilead Sciences
1
Janssen Scientific Affairs, LLC
1
Clinical Trials at Hospital CUF Descobertas
During the past decade, Hospital CUF Descobertas conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 3 clinical trials were completed, i.e. on
average, 18.8% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of the Efficacy and Safety of ABH001 in the Treatment of Patients With Epidermolysis Bullosa Who Have Wounds That Are Not Healing
2012-12-01
2013-11-01
Terminated
1
A Study Of PF-05280014 [Trastuzumab-Pfizer] Or Herceptin® [Trastuzumab-EU] Plus Paclitaxel In HER2 Positive First Line Metastatic Breast Cancer Treatment (REFLECTIONS B327-02)
2014-02-24
2020-06-27
Completed
707
A Study Of PF-05280586 (Rituximab-Pfizer) Or MabThera® (Rituximab-EU) For The First-Line Treatment Of Patients With CD20-Positive, Low Tumor Burden, Follicular Lymphoma (REFLECTIONS B328-06)
2014-09-30
2018-04-19
Completed
394
SPECTA: Screening Cancer Patients for Efficient Clinical Trial Access
2017-05-03
2026-03-01
Recruiting
4,975
Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
2017-01-01
2026-06-01
Active, not recruiting
431
Long-term Extension to Study AC-058B301 to Investigate Safety, Tolerability and Disease Control of Ponesimod 20 mg in Patients With Relapsing Multiple Sclerosis
2017-07-05
2024-01-18
Active, not recruiting
877
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Hospital CUF Descobertas" #1 sponsor was "Janssen Research & Development, LLC" with 2 trials, followed by "Pfizer" with 2 trials
sponsored, "Academia Cuf Descobertas" with 1 trials sponsored, "Actelion" with 1 trials sponsored and "Alector Inc."
with 1 trials sponsored. Other sponsors include 8 different institutions and
companies that sponsored additional 18 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital CUF Descobertas"
#1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "Brugmann University Hospital" with 1 trials as a collaborator, "CUF Academic and Research Medical Center" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "Helsinn Healthcare SA" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were
collaborators in the rest 17 trials.
Clinical Trials Conditions at Hospital CUF Descobertas
According to Clinical.Site data, the most researched conditions in "Hospital CUF Descobertas" are
"Follicular Lymphoma" (2 trials), "Advanced Cholangiocarcinoma" (1 trials), "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "All Tumor Types" (1 trials) and "Attention Deficit Hyperactivity Disorder" (1 trials). Many other conditions were trialed in "Hospital CUF Descobertas" in a lesser frequency.
Clinical Trials Intervention Types at Hospital CUF Descobertas
Most popular intervention types in "Hospital CUF Descobertas" are "Drug" (13 trials), "Biological" (3 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Carboplatin" (2 trials), "Cisplatin" (2 trials), "Placebo" (2 trials), "1L PEG + ASCORBIC ACID" (1 trials) and "5-FU" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Hospital CUF Descobertas
The vast majority of trials in "Hospital CUF Descobertas" are
18 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Hospital CUF Descobertas
Currently, there are NaN active trials in "Hospital CUF Descobertas".
undefined are not yet recruiting,
8 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Hospital CUF Descobertas,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Hospital CUF Descobertas, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 10 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".